申请人:Boehringer Mannheim GmbH
公开号:US05037849A1
公开(公告)日:1991-08-06
The present invention provides pharmaceutical compositions effective against angina-like heart and circulatory diseases containing at least one nitroxyalkylamine derivative of the general formula: ##STR1## wherein R.sub.1 is a hydrogen atom, a lower-alkyl radical, a C.sub.3 -C.sub.8 -cycloalkyl or C.sub.3 -C.sub.8 -cycloalkenyl radical, an aminocarbonyl, C.sub.1 -C.sub.6 -mono- or di-alkylaminocarbonyl radical, R.sup.2 is a hydrogen atom, a lower-alkyl radical or a C.sub.3 -C.sub.8 -cycloalkyl or cycloalkenyl radical or R.sup.2, together with R.sup.1 and the nitrogen atom to which they are attached, form a heteroaliphatic ring containing up to 6 carbon atoms, A is a valency bond or a straight-chained or branched lower-alkylene radical, in which a --CH.sub.2 -- group can be replaced by a cycloalkylene radical, B is a lower-alkylene radical, in which a --CH.sub.2 -- group can be replaced by a cycloalkylene radical and X is an --NR.sup.3 --CO-- or --CO--NR.sup.3 -- radical, in which R.sup.3 is a hydrogen atom or a lower-alkyl radical, when X is an --NR.sup.3 --CO-- radical, R.sup.3, together with the nitrogen atom and a carbon atom of the group A, bridge a heterocyclic ring containing 4 to 6 carbon atoms or R.sup.3, together with R.sup.2, A and the two nitrogen atoms, bridge a heterocyclic ring containing 3 to 5 carbon atoms; and the optically-active forms and physiologically acceptable salts thereof.
本发明提供了针对类似心绞痛和循环系统疾病的有效药物组合物,其中至少包含一种一般式的亚硝基烷基胺衍生物:其中R1是氢原子、较低的烷基基团、C3-C8-环烷基或C3-C8-环烯基基团、氨基甲酰基、C1-C6-单或双烷基氨基甲酰基团,R2是氢原子、较低的烷基基团或C3-C8-环烷基或环烯基基团,或者R2、连同R1和它们连接的氮原子,形成一个含有最多6个碳原子的杂原始环,A是一个价键或直链或分支的较低烷基烯基基团,其中一个--CH2--基团可以被环烷基烯基基团所取代,B是一个较低的烷基烯基基团,其中一个--CH2--基团可以被环烷基烯基基团所取代,X是一个--NR3--CO--或--CO--NR3--基团,其中R3是氢原子或较低的烷基基团,当X是一个--NR3--CO--基团时,R3、连同氮原子和A基团的一个碳原子,构成一个含有4至6个碳原子的杂环,或者R3、连同R2、A和两个氮原子,构成一个含有3至5个碳原子的杂环;以及其光学活性形式和生理上可接受的盐。